Health Condition 1: L400- Psoriasis vulgaris
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: ability to provide written informed consent Diagnosis of moderate to severe psoriasis by a dermatologist body surface area more then 5 Psoriasis of more then 1 year duration Psoriasis activity severity index PASI more then 7
Exclusion criteria
Exclusion criteria: Pregnant and lactating Women Patient With known malignancy patient on immunosuppressant therapy
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Primary outcome of the study is reduction in psoriasis area severity score within six months of treatment with individualized homoeopathic medicineTimepoint: total 18 months in which 6 months case record and 12 months observation | — |
Secondary
| Measure | Time frame |
|---|---|
| Change in biochemical values of serum calcium, serum uric acid and vitamin D Change in dermatology life quality index of patients before and after treatment To maintain and record the duration of remission after achieving at least 75% reduction in PASI SCORE To evaluate the effectiveness of homoeopathic medicine in inhibiting IL 17 and IL 23Timepoint: total 18 months in which 6 months case record and 12 months observation | — |
Countries
India
Contacts
Dr. MPK Homoeopathic Medical College Hospital and Research Centre Jaipur